Abstract
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is spreading all over the word. ACE2 is considered as the target receptor to invade humans. Hypertension is one of the most common non-communicable diseases. Many hypertensive patients are treated with RAAS inhibitors,whichare reported toincrease the expression of ACE2. Hence, whether hypertensive patients should continue the therapy of RAAS inhibitors has become the concern around the world. Considering the recent statements from several authoritative organizations, in this article, we make an in-depth discussion on the use of RAAS inhibitors for hypertensive patients.
| Translated title of the contribution | Treatment of RAAS inhibitors for hypertensive patients in the coronavirus disease 2019 pandemic from ESH/ISH/AHA statements |
|---|---|
| Original language | Chinese (Traditional) |
| Pages (from-to) | 802-806 |
| Number of pages | 5 |
| Journal | Journal of Xi'an Jiaotong University (Medical Sciences) |
| Volume | 41 |
| Issue number | 5 |
| DOIs | |
| State | Published - 5 Sep 2020 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Treatment of RAAS inhibitors for hypertensive patients in the coronavirus disease 2019 pandemic from ESH/ISH/AHA statements'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver